b-cell lymphoma 2
Cyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma
... Tissues from 75 patients, including 60 cases of CG, 11 cases of chronic cystitis (CC), and 4 cases of primary vesicle adenocarcinoma (ADC), were obtained from the Surgical Pathology Archives of the No. 2 People’s ...
5
Biological function of Lemur tyrosine kinase 2 (LMTK2): implications in neurodegeneration
... apoptotic B-cell lymphoma-2 (Bcl-2) and B-cell lymphoma-extra-large (Bcl-xL), and increases pro- apoptotic Bcl-2-interacting mediator of cell death ...
9
Mechanisms underlying dental-derived stem cell-mediated neurorestoration in neurodegenerative disorders
... stem cell; Bax: B-cell lymphoma 2-associated X protein; BBB: Blood – brain barrier; Bcl-2: B-cell lymphoma 2; BDNF: Brain-derived neurotrophic factor; ...
15
Original Article Expressions and clinical significance of Bcl-2, Bcl-xL and c-IAP1 protein in cervical cancer
... of B-cell lymphoma 2 (Bcl-2), B-cell lymphoma xL (Bcl-xL) and cellular inhibitor of apoptosis protein 1 (c-IAP1) protein in cervical cancer and nor- mal cervical ...
7
BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R
... 576.2], B-cell lymphoma 2 (Bcl-2) [GenBank:NM_000633], Bcl-2-interacting mediator of cell death (Bim) [Gen- ...Bank:NM_001204106.1], B-cell ...
10
IGH amplification in patients with B cell lymphoma unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt’s lymphoma
... for B-UNC/BL/DLBCL ...of lymphoma and among these, only the six cases of B-UNC/BL/DLBCL showed three or more copies of the IGH ...(cases 2, 3, 5 and 6) pre- sented with extranodal ...1, ...
6
<p>The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies – A Narrative Review</p>
... in B-cell non-Hodgkin lymphomas and in Hodgkin lymphoma that higher density of intratumoral macrophages is associated with progression and poor ...Figure 2 presents macrophages involve- ment ...
17
Evaluation of Prognostic Indicators in Non Hodgkin Lymphomas: The Role of Apoptotic and Proliferative Indices
... of B cell antigens in 119 Non Hodgkin lymphoma patients using a panel of CD3,5,10,20,23,30,38,79a,138, bcl- 2, MUM1/IRF4, cyclinD1 and Ki-67/Mib1 ...small B cell lymphomas are ...
118
www.ijcep.com /ISSN: 1936-2625/IJCEP1111004 Case Report Primary central nervous system B cell lymphoma with fea- tures intermediate between diffuse large B cell lymphoma and Burkitt lymphoma
... 2×3.2×2.2 cm mass in the right temporal lobe, a 1.9×1.6×1 cm mass in the right occipital lobe, and abnormal linear enhancement of the cauda equina (Figure 1). The right temporal lobe mass was biopsied with ...
5
Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia
... and B-cell receptor-mediated functions ...several lymphoma subtypes [32], including activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL) ...
6
Review Article Pitfalls in diagnostic hematopathology – Part II
... this lymphoma clustered with T-cell lymphomas rather than cHL [50], suggesting that it is a bona fide T-cell ...single cell analyses of cHL pointed to a B-cell origin [52, ...
8
Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution
... large cell lymphoma kinase-1), EMA (epithelial membrane antigen), cyclin D1, BCL-2, BCL-6, Mum1, and l light chain, Ki-67, Granzyme B, TIA-1 (T-cell intracytoplasmic antigen-1), TdT, ...
7
Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent
... elevation (890 U/L, upper normal 460 and 3176 ng/mL, upper normal 2150, respectively). Computed tomogra- phy (CT) revealed mediastinal lymphadenopathy and bilateral lung involvement. Histological examination of a lymph ...
6
The Pattern of CD15, CD30 and Bcl 2 Expression in Diffuse Large B Cell Lymphoma
... The Pattern of CD15, CD30 and Bcl 2 Expression in Diffuse Large B Cell Lymphoma ORIGINAL ARTICLE The Pattern of CD15, CD30 and Bcl 2 Expression in Diffuse Large B Cell Lymphoma G I Eow, MPath, L H Kim[.] ...
6
Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities
... [1, 2, ...large B-cell lymph- oma in the revised WHO classification of 2016, it has been reported to have unique clinicopathologic features and very poor outcomes with frequent relapse [2, 4, ...
6
<p>Clinical features and prognostic factors of primary bone marrow lymphoma</p>
... involvement; 2) absence of lymph node, spleen, liver, or other extra marrow involvement upon physical examination or imaging studies (including thoracic, abdominal, and pelvic enhanced computerized tomography ...
11
Immuno Phenotypic Study of Childhood Lymphoma with Special References to Gastrointestinal Lymphoma.
... Hodgkin’s Lymphoma is extremely rare in GIT. Only 2 cases were found by Lervin et al in a review of 117 lymphomas of the ...Non-Hodgkin’s lymphoma of either B or T cell type. Hodgkins ...
136
Targeting CD19 in B-cell lymphoma: emerging role of SAR3419
... Non-Hodgkin lymphoma symbolizes a heterogeneous group of diseases resulting from malignant transformation of lymphocytes with differing patterns of behavior and responses to ...non-Hodgkin lymphoma differs ...
9
Clinico-pathological analysis of lymphoproliferative disorders: a 3 year study
... Lymphoproliferative disorders are a heterogenous group of neoplasms of lymphoid cells, including B, T or NK cells. The incidence of these neoplasms has shown a rising trend in many countries. Lymphomas account for ...
5
Original Article Involvement of bone marrow in lymphoma: pathological investigation in a single-center from Northern China
... the thymus [14]; unlike SBLs, they do not express homing signals, and their clinical inva- sive behavior causes a short interval from onset to being diagnosed, which might be another important reason for their low occur- ...
10